Replimune (REPL) had the highest return between May 29, 2024 and June 13, 2024 by a small-cap US stock, returning 86.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Replimune (REPL) | 5/29/2024 - 6/13/2024 | 86.59% |
Advent Technologies (ADNWW) | 5/29/2024 - 6/13/2024 | 58% |
Stitch Fix (SFIX) | 5/29/2024 - 6/13/2024 | 57.08% |
Jumia Technologies (JMIA) | 5/29/2024 - 6/13/2024 | 55.59% |
Geron (GERN) | 5/29/2024 - 6/13/2024 | 47.43% |
Esperion Therapeutics (ESPR) | 5/29/2024 - 6/13/2024 | 40.58% |
Rezolute (RZLT) | 5/29/2024 - 6/13/2024 | 40.22% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 5/29/2024 - 6/13/2024 | 40.06% |
Know Labs (KNW) | 5/29/2024 - 6/13/2024 | 38.7% |
Olema Pharmaceuticals (OLMA) | 5/29/2024 - 6/13/2024 | 36.03% |
Eos Energy Enterprises (EOSE) | 5/29/2024 - 6/13/2024 | 34.13% |
Microvast (MVST) | 5/29/2024 - 6/13/2024 | 33.8% |
Rackspace Technology (RXT) | 5/29/2024 - 6/13/2024 | 33.51% |
Nano Nuclear Energy Inc Common Stock (NNE) | 5/29/2024 - 6/13/2024 | 33.15% |
Larimar Therapeutics (LRMR) | 5/29/2024 - 6/13/2024 | 33.1% |
Forward Air (FWRD) | 5/29/2024 - 6/13/2024 | 32.5% |
Taysha Gene Therapies (TSHA) | 5/29/2024 - 6/13/2024 | 32.38% |
Flotek Industries (FTK) | 5/29/2024 - 6/13/2024 | 31.62% |
Emergent Biosolutions (EBS) | 5/29/2024 - 6/13/2024 | 31.02% |
UroGen Pharma (URGN) | 5/29/2024 - 6/13/2024 | 30.6% |
Terns Pharmaceuticals (TERN) | 5/29/2024 - 6/13/2024 | 28.92% |
Navitas Semiconductor (NVTS) | 5/29/2024 - 6/13/2024 | 28.89% |
Rapport Therapeutics, Inc Common Stock (RAPP) | 5/29/2024 - 6/13/2024 | 28.06% |
Neogen (NEOG) | 5/29/2024 - 6/13/2024 | 28.03% |
Stoke Therapeutics (STOK) | 5/29/2024 - 6/13/2024 | 27.05% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
